Isabelle Laure Ray-Coquard, Elena Ioana Braicu, Kosei Hasegawa, Jung-Yun Lee, Xiaohua Wu, Destin Black, Nicole Concin, Claire Frances Friedman, Karim Nacerddine, Roisin Eilish O'Cearbhaill, Bhavana Pothuri. "FRAmework-01: A two-part phase 3 study of sofetabart mipitecan versus chemotherapy or mirvetuximab soravtansine in platinum-resistant ovarian cancer (PROC), and sofetabart mipitecan plus bevacizumab versus platinum-based chemotherapy plus bevacizumab in platinum-sensitive ovarian cancer (PSOC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps5644